Armonica

About:

Armonica is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.

Website: http://armonicatech.com/

Top Investors: National Human Genome Research Institute, Sun Mountain Capital, New Mexico Vintage Fund, Tramway Venture Partners, Cottonwood Technology Fund

Description:

Armonica Technologies derives its name from prolific innovator Benjamin Franklin’s favorite invention, The Glass Armonica. Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. The Company’s technology is based upon a portfolio of patented and patent pending technologies licensed from STC.UNM.

Total Funding Amount:

$5.95M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)armonicatech.com

Founders:

Steve Brueck

Number of Employees:

11-50

Last Funding Date:

2022-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai